💊 Quick Answer — GLP-1 Drug Comparison 2026
Zepbound produces the most weight loss (up to 22.5%). Wegovy has the strongest heart health evidence. Ozempic is a diabetes drug used off-label for weight loss. They are not the same medication.
- 🧪 Most weight lost: Zepbound (22.5%)
- ❤️ Best heart data: Wegovy
- 💉 Diabetes approved: Ozempic
- 💬 Always consult your doctor before starting
⚠️ Medical disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a licensed healthcare provider before starting, stopping, or changing any medication.
In This Article
What Are GLP-1 Medications?
GLP-1 medications — formally known as glucagon-like peptide-1 receptor agonists — mimic a natural gut hormone released after eating. That hormone signals your brain to feel full, slows digestion, and regulates blood sugar. By activating these receptors artificially, the drugs reduce appetite and help people eat significantly less — without relying on willpower alone.
Originally developed for type 2 diabetes, GLP-1 drugs have become the most-prescribed weight-loss medication class in the world. Ozempic, Wegovy, and Zepbound are the three you’ll hear most — but they’re not the same drug, or even the same type of medication.
What Is Ozempic?
Ozempic
Active: Semaglutide
Maker: Novo Nordisk
FDA: Type 2 Diabetes
Ozempic (semaglutide) is FDA-approved for type 2 diabetes management, not weight loss. It’s frequently prescribed off-label for obesity — legal, but its dosing (up to 2mg weekly) was optimised for blood sugar control, not maximum weight loss. It contains the same active ingredient as Wegovy but at a lower dose.
What Is Wegovy?
Wegovy
Active: Semaglutide
Maker: Novo Nordisk
FDA: Weight Management + CV
Wegovy uses the same semaglutide as Ozempic but at a higher dose (up to 2.4mg weekly) specifically approved for chronic weight management. It’s also approved to reduce cardiovascular risk. In 2026, Wegovy is available as both a weekly injection and a daily oral tablet — though the tablet produces slightly less weight loss than the injection.
What Is Zepbound?
Zepbound
Active: Tirzepatide
Maker: Eli Lilly
FDA: Weight Management
Zepbound (tirzepatide) is the most effective of the three. Unlike Ozempic and Wegovy which only target GLP-1, Zepbound activates two hormone pathways: GLP-1 and GIP (glucose-dependent insulinotropic polypeptide). This dual-action mechanism is why Zepbound consistently outperforms semaglutide in clinical trials for weight loss.
Ozempic vs Wegovy vs Zepbound: Head-to-Head Comparison
| Ozempic | Wegovy | Zepbound | |
|---|---|---|---|
| Active ingredient | Semaglutide | Semaglutide | Tirzepatide |
| Manufacturer | Novo Nordisk | Novo Nordisk | Eli Lilly |
| FDA approval | Type 2 diabetes | Weight mgmt + heart | Weight management |
| How taken | Weekly injection | Injection or daily pill | Weekly injection |
| Mechanism | GLP-1 only | GLP-1 only | 🔥 GLP-1 + GIP dual |
| Avg. weight loss | ~10–12% | 15–20.7% | 🏆 20.2–22.5% |
| Heart disease approval | Yes (diabetics) | ✅ Yes (broader) | Studies ongoing |
| List price/month | ~$900 | ~$1,349 | ~$1,060 |
Weight Loss Results: What the Clinical Data Says
Clinical trials give us the most reliable comparison. Here’s how average weight loss stacks up, based on data medically reviewed May 2026:
22.5%
🏆 Zepbound (injection)
SURMOUNT-1 trial at 72 weeks. Strongest result across all three drugs.
20.7%
Wegovy HD (injection)
High-dose injection version. Standard Wegovy injection: ~16.6%.
10-12%
Ozempic (diabetes dose)
Dosing optimised for blood sugar control, not weight loss.
📊 Real-world example: Someone weighing 220 lbs (100kg) could expect to lose ~45–50 lbs on Zepbound, ~33–36 lbs on Wegovy, and ~22–26 lbs on standard-dose Ozempic — assuming a reduced-calorie diet and long-term use.
Cost and Insurance Coverage in 2026
Cost remains one of the biggest barriers. All three carry high list prices, but real-world costs vary significantly:
Ozempic
~$900/mo
Better insurance coverage because it’s approved for diabetes. Patients with T2D have the best access.
Wegovy
~$1,349/mo
Highest list price. Coverage improving but many commercial plans still exclude weight-loss drugs.
Zepbound
~$25/mo*
*With Eli Lilly savings program for eligible commercially-insured patients. List price ~$1,060/mo.
🆕 Medicare GLP-1 Bridge Program: Starting July 1, 2026, eligible Medicare beneficiaries can access GLP-1 weight-loss drugs for the first time through this new program, running through December 31, 2027. For details, visit CMS.gov.
Side Effects to Know
All three share a similar side-effect profile since they all slow gastric emptying and suppress appetite:
🟡 Common (all three)
- Nausea (especially early on)
- Vomiting
- Diarrhea or constipation
- Stomach discomfort
🔴 Important warnings
- FDA black box warning on all three for thyroid C-cell tumour risk (animal studies)
- Not for people with personal/family history of medullary thyroid cancer or MEN 2
- Slightly more Zepbound patients stopped due to side effects vs semaglutide in trials
Which Medication Is Right for You?
👉 Choose Ozempic if…
You have type 2 diabetes and your primary goal is blood sugar control with weight loss as a bonus. Insurance coverage is strongest for this indication.
👉 Choose Wegovy if…
You want a drug approved specifically for weight management with the strongest cardiovascular evidence, or prefer the option of a daily pill instead of a weekly injection.
👉 Choose Zepbound if…
Maximum weight loss is your primary goal and you can access the Eli Lilly savings program ($25/mo for eligible commercially-insured patients).
The right choice depends on your health profile, goals, insurance, and side-effect tolerance. This decision must be made with a licensed healthcare provider who can review your full medical history.
Frequently Asked Questions
Is Ozempic the same as Wegovy?
No, but they contain the same active ingredient: semaglutide. The key difference is dosing and FDA approval. Ozempic is approved for type 2 diabetes at up to 2mg weekly. Wegovy is approved for weight management at a higher dose (up to 2.4mg weekly injection or 50mg daily tablet). Wegovy’s higher dose produces stronger weight loss results.
Which drug causes more weight loss: Wegovy or Zepbound?
Zepbound causes more weight loss on average. Clinical data shows average weight loss of 22.5% with Zepbound’s highest dose vs 20.7% with Wegovy HD (high-dose injection). Both significantly outperform standard Ozempic doses for weight loss.
Can I get these medications covered by Medicare in 2026?
Starting July 1, 2026, some Medicare beneficiaries can access GLP-1 weight-loss drugs through the new Medicare GLP-1 Bridge Program, which runs through December 31, 2027. Previously, Medicare Part D did not cover weight-loss medications. Contact your Medicare plan or CMS.gov for eligibility details.
What happens when you stop taking Ozempic, Wegovy, or Zepbound?
Most people regain a significant portion of lost weight after stopping. Clinical trials show weight regain typically begins within weeks of discontinuation. These medications are designed for long-term or indefinite use in most patients, not as short-term treatments.
Do you need to be obese to get a prescription?
Not necessarily. Both Wegovy and Zepbound are FDA-approved for adults with a BMI of 27 or higher (overweight) if they also have at least one weight-related condition such as high blood pressure, type 2 diabetes, or high cholesterol. A BMI of 30 or higher (obese) qualifies without a secondary condition. Ozempic requires a type 2 diabetes diagnosis.
